nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCC4—Conjugated Estrogens—osteoporosis	0.0911	0.614	CbGbCtD
Dipyridamole—ABCB1—Ethinyl Estradiol—osteoporosis	0.0241	0.162	CbGbCtD
Dipyridamole—ABCB1—Conjugated Estrogens—osteoporosis	0.0177	0.119	CbGbCtD
Dipyridamole—ABCB1—Estradiol—osteoporosis	0.0155	0.105	CbGbCtD
Dipyridamole—PRUNE—uterus—osteoporosis	0.00105	0.143	CbGeAlD
Dipyridamole—PDE6D—uterus—osteoporosis	0.00101	0.138	CbGeAlD
Dipyridamole—PDE6D—bone marrow—osteoporosis	0.00086	0.117	CbGeAlD
Dipyridamole—PDE2A—uterus—osteoporosis	0.000603	0.0822	CbGeAlD
Dipyridamole—PDE8B—uterus—osteoporosis	0.000575	0.0784	CbGeAlD
Dipyridamole—PDE8A—uterus—osteoporosis	0.000517	0.0705	CbGeAlD
Dipyridamole—PDE1A—uterus—osteoporosis	0.000501	0.0682	CbGeAlD
Dipyridamole—PDE3B—bone marrow—osteoporosis	0.000477	0.065	CbGeAlD
Dipyridamole—Cough—Zoledronate—osteoporosis	0.00042	0.00092	CcSEcCtD
Dipyridamole—Tachycardia—Pamidronate—osteoporosis	0.000419	0.000919	CcSEcCtD
Dipyridamole—Rash—Etidronic acid—osteoporosis	0.000417	0.000914	CcSEcCtD
Dipyridamole—Convulsion—Zoledronate—osteoporosis	0.000417	0.000913	CcSEcCtD
Dipyridamole—Dermatitis—Etidronic acid—osteoporosis	0.000416	0.000913	CcSEcCtD
Dipyridamole—Vertigo—Conjugated Estrogens—osteoporosis	0.000416	0.000912	CcSEcCtD
Dipyridamole—Hyperhidrosis—Pamidronate—osteoporosis	0.000415	0.000911	CcSEcCtD
Dipyridamole—Syncope—Conjugated Estrogens—osteoporosis	0.000415	0.00091	CcSEcCtD
Dipyridamole—Hypertension—Zoledronate—osteoporosis	0.000415	0.00091	CcSEcCtD
Dipyridamole—Hypersensitivity—Alendronate—osteoporosis	0.000415	0.00091	CcSEcCtD
Dipyridamole—Headache—Etidronic acid—osteoporosis	0.000414	0.000908	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000412	0.000903	CcSEcCtD
Dipyridamole—Asthenia—Estropipate—osteoporosis	0.00041	0.000899	CcSEcCtD
Dipyridamole—Myalgia—Zoledronate—osteoporosis	0.000409	0.000897	CcSEcCtD
Dipyridamole—Arthralgia—Zoledronate—osteoporosis	0.000409	0.000897	CcSEcCtD
Dipyridamole—Chest pain—Zoledronate—osteoporosis	0.000409	0.000897	CcSEcCtD
Dipyridamole—Palpitations—Conjugated Estrogens—osteoporosis	0.000409	0.000897	CcSEcCtD
Dipyridamole—Anxiety—Zoledronate—osteoporosis	0.000408	0.000894	CcSEcCtD
Dipyridamole—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000407	0.000892	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000407	0.000891	CcSEcCtD
Dipyridamole—Paraesthesia—Risedronate—osteoporosis	0.000406	0.00089	CcSEcCtD
Dipyridamole—Pruritus—Estropipate—osteoporosis	0.000405	0.000887	CcSEcCtD
Dipyridamole—Discomfort—Zoledronate—osteoporosis	0.000405	0.000887	CcSEcCtD
Dipyridamole—Asthenia—Alendronate—osteoporosis	0.000404	0.000886	CcSEcCtD
Dipyridamole—Hypersensitivity—Ibandronate—osteoporosis	0.000404	0.000886	CcSEcCtD
Dipyridamole—Cough—Conjugated Estrogens—osteoporosis	0.000404	0.000886	CcSEcCtD
Dipyridamole—Dyspnoea—Risedronate—osteoporosis	0.000403	0.000883	CcSEcCtD
Dipyridamole—Hypotension—Pamidronate—osteoporosis	0.000402	0.00088	CcSEcCtD
Dipyridamole—Convulsion—Conjugated Estrogens—osteoporosis	0.000401	0.000879	CcSEcCtD
Dipyridamole—Dry mouth—Zoledronate—osteoporosis	0.0004	0.000878	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.0004	0.000877	CcSEcCtD
Dipyridamole—Fatigue—Ethinyl Estradiol—osteoporosis	0.0004	0.000876	CcSEcCtD
Dipyridamole—Pruritus—Alendronate—osteoporosis	0.000399	0.000874	CcSEcCtD
Dipyridamole—Dyspepsia—Risedronate—osteoporosis	0.000398	0.000872	CcSEcCtD
Dipyridamole—Tinnitus—Estradiol—osteoporosis	0.000397	0.00087	CcSEcCtD
Dipyridamole—Hypersensitivity—Calcitriol—osteoporosis	0.000396	0.000867	CcSEcCtD
Dipyridamole—Flushing—Estradiol—osteoporosis	0.000395	0.000866	CcSEcCtD
Dipyridamole—Cardiac disorder—Estradiol—osteoporosis	0.000395	0.000866	CcSEcCtD
Dipyridamole—Arthralgia—Conjugated Estrogens—osteoporosis	0.000394	0.000864	CcSEcCtD
Dipyridamole—Chest pain—Conjugated Estrogens—osteoporosis	0.000394	0.000864	CcSEcCtD
Dipyridamole—Myalgia—Conjugated Estrogens—osteoporosis	0.000394	0.000864	CcSEcCtD
Dipyridamole—Asthenia—Ibandronate—osteoporosis	0.000394	0.000863	CcSEcCtD
Dipyridamole—Anxiety—Conjugated Estrogens—osteoporosis	0.000393	0.000861	CcSEcCtD
Dipyridamole—Nausea—Etidronic acid—osteoporosis	0.000393	0.000861	CcSEcCtD
Dipyridamole—Anaphylactic shock—Zoledronate—osteoporosis	0.000393	0.00086	CcSEcCtD
Dipyridamole—Oedema—Zoledronate—osteoporosis	0.000393	0.00086	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000392	0.000858	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000392	0.000858	CcSEcCtD
Dipyridamole—Diarrhoea—Estropipate—osteoporosis	0.000391	0.000858	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Risedronate—osteoporosis	0.00039	0.000855	CcSEcCtD
Dipyridamole—Fatigue—Risedronate—osteoporosis	0.00039	0.000854	CcSEcCtD
Dipyridamole—Pruritus—Ibandronate—osteoporosis	0.000388	0.000851	CcSEcCtD
Dipyridamole—Pain—Risedronate—osteoporosis	0.000387	0.000847	CcSEcCtD
Dipyridamole—Angiopathy—Estradiol—osteoporosis	0.000386	0.000847	CcSEcCtD
Dipyridamole—Shock—Zoledronate—osteoporosis	0.000386	0.000846	CcSEcCtD
Dipyridamole—Paraesthesia—Pamidronate—osteoporosis	0.000386	0.000846	CcSEcCtD
Dipyridamole—Diarrhoea—Alendronate—osteoporosis	0.000385	0.000845	CcSEcCtD
Dipyridamole—Asthenia—Calcitriol—osteoporosis	0.000385	0.000844	CcSEcCtD
Dipyridamole—Nervous system disorder—Zoledronate—osteoporosis	0.000385	0.000844	CcSEcCtD
Dipyridamole—Immune system disorder—Estradiol—osteoporosis	0.000385	0.000843	CcSEcCtD
Dipyridamole—Thrombocytopenia—Zoledronate—osteoporosis	0.000384	0.000842	CcSEcCtD
Dipyridamole—Mediastinal disorder—Estradiol—osteoporosis	0.000384	0.000841	CcSEcCtD
Dipyridamole—Dyspnoea—Pamidronate—osteoporosis	0.000383	0.00084	CcSEcCtD
Dipyridamole—Tachycardia—Zoledronate—osteoporosis	0.000383	0.00084	CcSEcCtD
Dipyridamole—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000382	0.000837	CcSEcCtD
Dipyridamole—Chills—Estradiol—osteoporosis	0.000382	0.000837	CcSEcCtD
Dipyridamole—Somnolence—Pamidronate—osteoporosis	0.000382	0.000837	CcSEcCtD
Dipyridamole—Skin disorder—Zoledronate—osteoporosis	0.000381	0.000836	CcSEcCtD
Dipyridamole—Pruritus—Calcitriol—osteoporosis	0.00038	0.000833	CcSEcCtD
Dipyridamole—Hyperhidrosis—Zoledronate—osteoporosis	0.000379	0.000832	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000379	0.000831	CcSEcCtD
Dipyridamole—Diarrhoea—Raloxifene—osteoporosis	0.000379	0.000831	CcSEcCtD
Dipyridamole—Dyspepsia—Pamidronate—osteoporosis	0.000378	0.000829	CcSEcCtD
Dipyridamole—Dizziness—Estropipate—osteoporosis	0.000378	0.000829	CcSEcCtD
Dipyridamole—Oedema—Conjugated Estrogens—osteoporosis	0.000378	0.000828	CcSEcCtD
Dipyridamole—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000378	0.000828	CcSEcCtD
Dipyridamole—Alopecia—Estradiol—osteoporosis	0.000376	0.000825	CcSEcCtD
Dipyridamole—Diarrhoea—Ibandronate—osteoporosis	0.000375	0.000823	CcSEcCtD
Dipyridamole—Dizziness—Alendronate—osteoporosis	0.000373	0.000817	CcSEcCtD
Dipyridamole—Shock—Conjugated Estrogens—osteoporosis	0.000372	0.000815	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000371	0.000813	CcSEcCtD
Dipyridamole—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000371	0.000812	CcSEcCtD
Dipyridamole—Fatigue—Pamidronate—osteoporosis	0.00037	0.000812	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Risedronate—osteoporosis	0.00037	0.00081	CcSEcCtD
Dipyridamole—Tachycardia—Conjugated Estrogens—osteoporosis	0.000369	0.000808	CcSEcCtD
Dipyridamole—Urticaria—Ethinyl Estradiol—osteoporosis	0.000368	0.000807	CcSEcCtD
Dipyridamole—Pain—Pamidronate—osteoporosis	0.000367	0.000805	CcSEcCtD
Dipyridamole—Diarrhoea—Calcitriol—osteoporosis	0.000367	0.000805	CcSEcCtD
Dipyridamole—Skin disorder—Conjugated Estrogens—osteoporosis	0.000367	0.000805	CcSEcCtD
Dipyridamole—Hypotension—Zoledronate—osteoporosis	0.000367	0.000804	CcSEcCtD
Dipyridamole—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000367	0.000803	CcSEcCtD
Dipyridamole—Dizziness—Raloxifene—osteoporosis	0.000366	0.000803	CcSEcCtD
Dipyridamole—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000365	0.000801	CcSEcCtD
Dipyridamole—Flatulence—Estradiol—osteoporosis	0.000365	0.0008	CcSEcCtD
Dipyridamole—Tension—Estradiol—osteoporosis	0.000364	0.000797	CcSEcCtD
Dipyridamole—Vomiting—Estropipate—osteoporosis	0.000364	0.000797	CcSEcCtD
Dipyridamole—Dysgeusia—Estradiol—osteoporosis	0.000363	0.000796	CcSEcCtD
Dipyridamole—Dizziness—Ibandronate—osteoporosis	0.000363	0.000795	CcSEcCtD
Dipyridamole—ADA—bone marrow—osteoporosis	0.000361	0.0492	CbGeAlD
Dipyridamole—Rash—Estropipate—osteoporosis	0.000361	0.00079	CcSEcCtD
Dipyridamole—Dermatitis—Estropipate—osteoporosis	0.00036	0.00079	CcSEcCtD
Dipyridamole—Nervousness—Estradiol—osteoporosis	0.00036	0.000789	CcSEcCtD
Dipyridamole—Urticaria—Risedronate—osteoporosis	0.000359	0.000787	CcSEcCtD
Dipyridamole—Back pain—Estradiol—osteoporosis	0.000359	0.000786	CcSEcCtD
Dipyridamole—Headache—Estropipate—osteoporosis	0.000358	0.000785	CcSEcCtD
Dipyridamole—Vomiting—Alendronate—osteoporosis	0.000358	0.000785	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000358	0.000784	CcSEcCtD
Dipyridamole—Abdominal pain—Risedronate—osteoporosis	0.000357	0.000783	CcSEcCtD
Dipyridamole—Muscle spasms—Estradiol—osteoporosis	0.000356	0.000781	CcSEcCtD
Dipyridamole—Rash—Alendronate—osteoporosis	0.000355	0.000779	CcSEcCtD
Dipyridamole—Dermatitis—Alendronate—osteoporosis	0.000355	0.000778	CcSEcCtD
Dipyridamole—Feeling abnormal—Pamidronate—osteoporosis	0.000354	0.000776	CcSEcCtD
Dipyridamole—Hypotension—Conjugated Estrogens—osteoporosis	0.000353	0.000774	CcSEcCtD
Dipyridamole—Headache—Alendronate—osteoporosis	0.000353	0.000774	CcSEcCtD
Dipyridamole—Paraesthesia—Zoledronate—osteoporosis	0.000352	0.000773	CcSEcCtD
Dipyridamole—Vomiting—Raloxifene—osteoporosis	0.000352	0.000772	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Pamidronate—osteoporosis	0.000351	0.00077	CcSEcCtD
Dipyridamole—Dyspnoea—Zoledronate—osteoporosis	0.00035	0.000767	CcSEcCtD
Dipyridamole—Rash—Raloxifene—osteoporosis	0.000349	0.000766	CcSEcCtD
Dipyridamole—Dermatitis—Raloxifene—osteoporosis	0.000349	0.000765	CcSEcCtD
Dipyridamole—Somnolence—Zoledronate—osteoporosis	0.000349	0.000765	CcSEcCtD
Dipyridamole—Vomiting—Ibandronate—osteoporosis	0.000349	0.000764	CcSEcCtD
Dipyridamole—Tremor—Estradiol—osteoporosis	0.000347	0.000761	CcSEcCtD
Dipyridamole—Headache—Raloxifene—osteoporosis	0.000347	0.000761	CcSEcCtD
Dipyridamole—Rash—Ibandronate—osteoporosis	0.000346	0.000758	CcSEcCtD
Dipyridamole—Dermatitis—Ibandronate—osteoporosis	0.000346	0.000757	CcSEcCtD
Dipyridamole—Dyspepsia—Zoledronate—osteoporosis	0.000346	0.000757	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000344	0.000755	CcSEcCtD
Dipyridamole—Ill-defined disorder—Estradiol—osteoporosis	0.000344	0.000754	CcSEcCtD
Dipyridamole—Headache—Ibandronate—osteoporosis	0.000344	0.000753	CcSEcCtD
Dipyridamole—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000342	0.000749	CcSEcCtD
Dipyridamole—Vomiting—Calcitriol—osteoporosis	0.000341	0.000748	CcSEcCtD
Dipyridamole—Nausea—Estropipate—osteoporosis	0.00034	0.000745	CcSEcCtD
Dipyridamole—Abdominal pain—Pamidronate—osteoporosis	0.00034	0.000745	CcSEcCtD
Dipyridamole—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000339	0.000744	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000339	0.000743	CcSEcCtD
Dipyridamole—Angioedema—Estradiol—osteoporosis	0.000339	0.000742	CcSEcCtD
Dipyridamole—Rash—Calcitriol—osteoporosis	0.000339	0.000742	CcSEcCtD
Dipyridamole—Fatigue—Zoledronate—osteoporosis	0.000338	0.000742	CcSEcCtD
Dipyridamole—Dermatitis—Calcitriol—osteoporosis	0.000338	0.000741	CcSEcCtD
Dipyridamole—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000337	0.000739	CcSEcCtD
Dipyridamole—Headache—Calcitriol—osteoporosis	0.000336	0.000737	CcSEcCtD
Dipyridamole—Somnolence—Conjugated Estrogens—osteoporosis	0.000336	0.000736	CcSEcCtD
Dipyridamole—Pain—Zoledronate—osteoporosis	0.000336	0.000736	CcSEcCtD
Dipyridamole—Nausea—Alendronate—osteoporosis	0.000335	0.000733	CcSEcCtD
Dipyridamole—Malaise—Estradiol—osteoporosis	0.000334	0.000733	CcSEcCtD
Dipyridamole—Hypersensitivity—Risedronate—osteoporosis	0.000333	0.00073	CcSEcCtD
Dipyridamole—Vertigo—Estradiol—osteoporosis	0.000333	0.00073	CcSEcCtD
Dipyridamole—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000333	0.000729	CcSEcCtD
Dipyridamole—Asthenia—Ethinyl Estradiol—osteoporosis	0.000333	0.000729	CcSEcCtD
Dipyridamole—Syncope—Estradiol—osteoporosis	0.000332	0.000728	CcSEcCtD
Dipyridamole—Nausea—Raloxifene—osteoporosis	0.000329	0.000721	CcSEcCtD
Dipyridamole—Pruritus—Ethinyl Estradiol—osteoporosis	0.000328	0.000719	CcSEcCtD
Dipyridamole—Palpitations—Estradiol—osteoporosis	0.000328	0.000718	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000326	0.000715	CcSEcCtD
Dipyridamole—Fatigue—Conjugated Estrogens—osteoporosis	0.000326	0.000714	CcSEcCtD
Dipyridamole—Nausea—Ibandronate—osteoporosis	0.000326	0.000714	CcSEcCtD
Dipyridamole—Loss of consciousness—Estradiol—osteoporosis	0.000326	0.000714	CcSEcCtD
Dipyridamole—Asthenia—Risedronate—osteoporosis	0.000324	0.000711	CcSEcCtD
Dipyridamole—Feeling abnormal—Zoledronate—osteoporosis	0.000323	0.000709	CcSEcCtD
Dipyridamole—Cough—Estradiol—osteoporosis	0.000323	0.000709	CcSEcCtD
Dipyridamole—Pain—Conjugated Estrogens—osteoporosis	0.000323	0.000708	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Zoledronate—osteoporosis	0.000321	0.000703	CcSEcCtD
Dipyridamole—Hypertension—Estradiol—osteoporosis	0.00032	0.000701	CcSEcCtD
Dipyridamole—Pruritus—Risedronate—osteoporosis	0.00032	0.000701	CcSEcCtD
Dipyridamole—Nausea—Calcitriol—osteoporosis	0.000319	0.000699	CcSEcCtD
Dipyridamole—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000317	0.000695	CcSEcCtD
Dipyridamole—Hypersensitivity—Pamidronate—osteoporosis	0.000317	0.000694	CcSEcCtD
Dipyridamole—Arthralgia—Estradiol—osteoporosis	0.000316	0.000692	CcSEcCtD
Dipyridamole—Myalgia—Estradiol—osteoporosis	0.000316	0.000692	CcSEcCtD
Dipyridamole—Chest pain—Estradiol—osteoporosis	0.000316	0.000692	CcSEcCtD
Dipyridamole—Anxiety—Estradiol—osteoporosis	0.000314	0.000689	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000313	0.000687	CcSEcCtD
Dipyridamole—Urticaria—Zoledronate—osteoporosis	0.000312	0.000683	CcSEcCtD
Dipyridamole—Discomfort—Estradiol—osteoporosis	0.000312	0.000683	CcSEcCtD
Dipyridamole—Abdominal pain—Zoledronate—osteoporosis	0.00031	0.00068	CcSEcCtD
Dipyridamole—Diarrhoea—Risedronate—osteoporosis	0.000309	0.000678	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000309	0.000677	CcSEcCtD
Dipyridamole—Dry mouth—Estradiol—osteoporosis	0.000309	0.000676	CcSEcCtD
Dipyridamole—Asthenia—Pamidronate—osteoporosis	0.000308	0.000676	CcSEcCtD
Dipyridamole—Dizziness—Ethinyl Estradiol—osteoporosis	0.000307	0.000672	CcSEcCtD
Dipyridamole—Pruritus—Pamidronate—osteoporosis	0.000304	0.000666	CcSEcCtD
Dipyridamole—Anaphylactic shock—Estradiol—osteoporosis	0.000302	0.000663	CcSEcCtD
Dipyridamole—Oedema—Estradiol—osteoporosis	0.000302	0.000663	CcSEcCtD
Dipyridamole—Urticaria—Conjugated Estrogens—osteoporosis	0.0003	0.000658	CcSEcCtD
Dipyridamole—Dizziness—Risedronate—osteoporosis	0.000299	0.000655	CcSEcCtD
Dipyridamole—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000299	0.000655	CcSEcCtD
Dipyridamole—Shock—Estradiol—osteoporosis	0.000298	0.000652	CcSEcCtD
Dipyridamole—Nervous system disorder—Estradiol—osteoporosis	0.000297	0.00065	CcSEcCtD
Dipyridamole—SLC29A1—uterus—osteoporosis	0.000296	0.0404	CbGeAlD
Dipyridamole—Tachycardia—Estradiol—osteoporosis	0.000295	0.000647	CcSEcCtD
Dipyridamole—Vomiting—Ethinyl Estradiol—osteoporosis	0.000295	0.000646	CcSEcCtD
Dipyridamole—Diarrhoea—Pamidronate—osteoporosis	0.000294	0.000644	CcSEcCtD
Dipyridamole—Skin disorder—Estradiol—osteoporosis	0.000294	0.000644	CcSEcCtD
Dipyridamole—Hyperhidrosis—Estradiol—osteoporosis	0.000292	0.000641	CcSEcCtD
Dipyridamole—Rash—Ethinyl Estradiol—osteoporosis	0.000292	0.000641	CcSEcCtD
Dipyridamole—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000292	0.00064	CcSEcCtD
Dipyridamole—Headache—Ethinyl Estradiol—osteoporosis	0.00029	0.000637	CcSEcCtD
Dipyridamole—Hypersensitivity—Zoledronate—osteoporosis	0.000289	0.000634	CcSEcCtD
Dipyridamole—Vomiting—Risedronate—osteoporosis	0.000287	0.00063	CcSEcCtD
Dipyridamole—Rash—Risedronate—osteoporosis	0.000285	0.000625	CcSEcCtD
Dipyridamole—Dermatitis—Risedronate—osteoporosis	0.000285	0.000624	CcSEcCtD
Dipyridamole—Dizziness—Pamidronate—osteoporosis	0.000284	0.000623	CcSEcCtD
Dipyridamole—Headache—Risedronate—osteoporosis	0.000283	0.000621	CcSEcCtD
Dipyridamole—Asthenia—Zoledronate—osteoporosis	0.000282	0.000617	CcSEcCtD
Dipyridamole—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000278	0.00061	CcSEcCtD
Dipyridamole—Pruritus—Zoledronate—osteoporosis	0.000278	0.000609	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000276	0.000604	CcSEcCtD
Dipyridamole—Nausea—Ethinyl Estradiol—osteoporosis	0.000275	0.000604	CcSEcCtD
Dipyridamole—ABCC5—bone marrow—osteoporosis	0.000274	0.0373	CbGeAlD
Dipyridamole—Vomiting—Pamidronate—osteoporosis	0.000273	0.000599	CcSEcCtD
Dipyridamole—Paraesthesia—Estradiol—osteoporosis	0.000272	0.000595	CcSEcCtD
Dipyridamole—Asthenia—Conjugated Estrogens—osteoporosis	0.000271	0.000594	CcSEcCtD
Dipyridamole—Rash—Pamidronate—osteoporosis	0.000271	0.000594	CcSEcCtD
Dipyridamole—Dermatitis—Pamidronate—osteoporosis	0.000271	0.000593	CcSEcCtD
Dipyridamole—Dyspnoea—Estradiol—osteoporosis	0.00027	0.000591	CcSEcCtD
Dipyridamole—Headache—Pamidronate—osteoporosis	0.000269	0.00059	CcSEcCtD
Dipyridamole—Somnolence—Estradiol—osteoporosis	0.000269	0.000589	CcSEcCtD
Dipyridamole—Diarrhoea—Zoledronate—osteoporosis	0.000269	0.000589	CcSEcCtD
Dipyridamole—Nausea—Risedronate—osteoporosis	0.000269	0.000589	CcSEcCtD
Dipyridamole—Pruritus—Conjugated Estrogens—osteoporosis	0.000267	0.000586	CcSEcCtD
Dipyridamole—Dyspepsia—Estradiol—osteoporosis	0.000266	0.000584	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Estradiol—osteoporosis	0.000261	0.000572	CcSEcCtD
Dipyridamole—Fatigue—Estradiol—osteoporosis	0.000261	0.000572	CcSEcCtD
Dipyridamole—Dizziness—Zoledronate—osteoporosis	0.00026	0.000569	CcSEcCtD
Dipyridamole—Pain—Estradiol—osteoporosis	0.000259	0.000567	CcSEcCtD
Dipyridamole—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000259	0.000567	CcSEcCtD
Dipyridamole—Nausea—Pamidronate—osteoporosis	0.000255	0.000559	CcSEcCtD
Dipyridamole—SLC29A1—bone marrow—osteoporosis	0.000251	0.0343	CbGeAlD
Dipyridamole—Dizziness—Conjugated Estrogens—osteoporosis	0.00025	0.000548	CcSEcCtD
Dipyridamole—Vomiting—Zoledronate—osteoporosis	0.00025	0.000547	CcSEcCtD
Dipyridamole—Feeling abnormal—Estradiol—osteoporosis	0.000249	0.000546	CcSEcCtD
Dipyridamole—Rash—Zoledronate—osteoporosis	0.000247	0.000542	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Estradiol—osteoporosis	0.000247	0.000542	CcSEcCtD
Dipyridamole—Dermatitis—Zoledronate—osteoporosis	0.000247	0.000542	CcSEcCtD
Dipyridamole—Headache—Zoledronate—osteoporosis	0.000246	0.000539	CcSEcCtD
Dipyridamole—Vomiting—Conjugated Estrogens—osteoporosis	0.00024	0.000527	CcSEcCtD
Dipyridamole—Urticaria—Estradiol—osteoporosis	0.00024	0.000527	CcSEcCtD
Dipyridamole—Abdominal pain—Estradiol—osteoporosis	0.000239	0.000524	CcSEcCtD
Dipyridamole—Rash—Conjugated Estrogens—osteoporosis	0.000238	0.000522	CcSEcCtD
Dipyridamole—Dermatitis—Conjugated Estrogens—osteoporosis	0.000238	0.000522	CcSEcCtD
Dipyridamole—Headache—Conjugated Estrogens—osteoporosis	0.000237	0.000519	CcSEcCtD
Dipyridamole—Nausea—Zoledronate—osteoporosis	0.000233	0.000511	CcSEcCtD
Dipyridamole—Nausea—Conjugated Estrogens—osteoporosis	0.000224	0.000492	CcSEcCtD
Dipyridamole—ABCC4—uterus—osteoporosis	0.000224	0.0305	CbGeAlD
Dipyridamole—Hypersensitivity—Estradiol—osteoporosis	0.000223	0.000488	CcSEcCtD
Dipyridamole—Asthenia—Estradiol—osteoporosis	0.000217	0.000476	CcSEcCtD
Dipyridamole—Pruritus—Estradiol—osteoporosis	0.000214	0.000469	CcSEcCtD
Dipyridamole—Diarrhoea—Estradiol—osteoporosis	0.000207	0.000454	CcSEcCtD
Dipyridamole—Dizziness—Estradiol—osteoporosis	0.0002	0.000438	CcSEcCtD
Dipyridamole—Vomiting—Estradiol—osteoporosis	0.000192	0.000422	CcSEcCtD
Dipyridamole—Rash—Estradiol—osteoporosis	0.000191	0.000418	CcSEcCtD
Dipyridamole—Dermatitis—Estradiol—osteoporosis	0.000191	0.000418	CcSEcCtD
Dipyridamole—ABCC4—bone marrow—osteoporosis	0.00019	0.0259	CbGeAlD
Dipyridamole—Headache—Estradiol—osteoporosis	0.000189	0.000415	CcSEcCtD
Dipyridamole—Nausea—Estradiol—osteoporosis	0.00018	0.000394	CcSEcCtD
Dipyridamole—ABCB1—uterus—osteoporosis	7.78e-05	0.0106	CbGeAlD
Dipyridamole—ABCB1—bone marrow—osteoporosis	6.6e-05	0.009	CbGeAlD
Dipyridamole—PDE1C—Signaling Pathways—ESR1—osteoporosis	4e-05	0.000103	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.96e-05	0.000102	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—MTHFR—osteoporosis	3.94e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—ESR1—osteoporosis	3.94e-05	0.000102	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PSMA5—osteoporosis	3.93e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PSMA2—osteoporosis	3.93e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—POMC—osteoporosis	3.91e-05	0.000101	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CALCA—osteoporosis	3.9e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KL—osteoporosis	3.88e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—POMC—osteoporosis	3.88e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—POMC—osteoporosis	3.88e-05	0.0001	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by NGF—IL6—osteoporosis	3.88e-05	9.99e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—ESR1—osteoporosis	3.84e-05	9.9e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—CYP19A1—osteoporosis	3.81e-05	9.82e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TGFB1—osteoporosis	3.81e-05	9.81e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—BMP2—osteoporosis	3.81e-05	9.8e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PTHLH—osteoporosis	3.81e-05	9.8e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—POMC—osteoporosis	3.8e-05	9.79e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—POMC—osteoporosis	3.79e-05	9.76e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6R—osteoporosis	3.79e-05	9.75e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6R—osteoporosis	3.79e-05	9.75e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—IGF1—osteoporosis	3.77e-05	9.71e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.76e-05	9.7e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IRS1—osteoporosis	3.74e-05	9.62e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IGF1—osteoporosis	3.73e-05	9.62e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IGF1—osteoporosis	3.73e-05	9.62e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—FGB—osteoporosis	3.72e-05	9.59e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—ADCY5—osteoporosis	3.72e-05	9.59e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—ADCY5—osteoporosis	3.72e-05	9.59e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AGER—osteoporosis	3.7e-05	9.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—TNF—osteoporosis	3.7e-05	9.52e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6R—osteoporosis	3.7e-05	9.52e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—ADCY5—osteoporosis	3.69e-05	9.5e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IRS1—osteoporosis	3.69e-05	9.49e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CALCA—osteoporosis	3.66e-05	9.44e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KL—osteoporosis	3.64e-05	9.37e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—POMC—osteoporosis	3.6e-05	9.27e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PSMA5—osteoporosis	3.6e-05	9.26e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PSMA2—osteoporosis	3.6e-05	9.26e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IRS1—osteoporosis	3.59e-05	9.25e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—POMC—osteoporosis	3.57e-05	9.2e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—POMC—osteoporosis	3.55e-05	9.14e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—POMC—osteoporosis	3.55e-05	9.14e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—IL6—osteoporosis	3.55e-05	9.14e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KL—osteoporosis	3.54e-05	9.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IRS2—osteoporosis	3.53e-05	9.08e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6R—osteoporosis	3.51e-05	9.04e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PKM—osteoporosis	3.47e-05	8.95e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—FDPS—osteoporosis	3.47e-05	8.95e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TGFB1—osteoporosis	3.47e-05	8.93e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6R—osteoporosis	3.46e-05	8.92e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IGF1—osteoporosis	3.46e-05	8.91e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6R—osteoporosis	3.46e-05	8.91e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—POMC—osteoporosis	3.46e-05	8.91e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—POMC—osteoporosis	3.45e-05	8.89e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—IL6—osteoporosis	3.44e-05	8.87e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—IL6—osteoporosis	3.44e-05	8.87e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MTHFR—osteoporosis	3.42e-05	8.82e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MTHFR—osteoporosis	3.42e-05	8.82e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—IL6—osteoporosis	3.42e-05	8.8e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—IL6—osteoporosis	3.42e-05	8.8e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IGF1—osteoporosis	3.41e-05	8.79e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—ADCY5—osteoporosis	3.4e-05	8.77e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6R—osteoporosis	3.37e-05	8.69e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6R—osteoporosis	3.37e-05	8.67e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—IL6—osteoporosis	3.36e-05	8.65e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CALCA—osteoporosis	3.35e-05	8.63e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IGF1—osteoporosis	3.33e-05	8.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KL—osteoporosis	3.33e-05	8.57e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PGLS—osteoporosis	3.29e-05	8.48e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GPD2—osteoporosis	3.29e-05	8.48e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—POMC—osteoporosis	3.27e-05	8.42e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TGFB1—osteoporosis	3.26e-05	8.4e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	3.26e-05	8.39e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IRS2—osteoporosis	3.26e-05	8.39e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IRS2—osteoporosis	3.26e-05	8.39e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—POMC—osteoporosis	3.24e-05	8.36e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IRS2—osteoporosis	3.22e-05	8.31e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—MYC—osteoporosis	3.18e-05	8.2e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—MYC—osteoporosis	3.18e-05	8.2e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TGFB1—osteoporosis	3.18e-05	8.18e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TGFB1—osteoporosis	3.18e-05	8.18e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6R—osteoporosis	3.16e-05	8.15e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—POMC—osteoporosis	3.15e-05	8.13e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MTHFR—osteoporosis	3.13e-05	8.06e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ADCY5—osteoporosis	3.12e-05	8.03e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—GPX1—osteoporosis	3.11e-05	8e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IRS1—osteoporosis	3.08e-05	7.93e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—IL6—osteoporosis	3.07e-05	7.91e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ADCY5—osteoporosis	3.04e-05	7.84e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KL—osteoporosis	3.04e-05	7.84e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PNP—osteoporosis	3.01e-05	7.76e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ATIC—osteoporosis	3.01e-05	7.76e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TGFB1—osteoporosis	2.98e-05	7.68e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IRS2—osteoporosis	2.98e-05	7.67e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—MYC—osteoporosis	2.97e-05	7.65e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—POMC—osteoporosis	2.97e-05	7.64e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—TGFB1—osteoporosis	2.96e-05	7.63e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SPP1—osteoporosis	2.94e-05	7.58e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—MYC—osteoporosis	2.93e-05	7.55e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—TGFB1—osteoporosis	2.92e-05	7.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6R—osteoporosis	2.89e-05	7.46e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6R—osteoporosis	2.89e-05	7.45e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—MTHFR—osteoporosis	2.87e-05	7.38e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL6—osteoporosis	2.85e-05	7.35e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL6—osteoporosis	2.85e-05	7.35e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ADCY5—osteoporosis	2.85e-05	7.34e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IRS1—osteoporosis	2.84e-05	7.32e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IRS1—osteoporosis	2.84e-05	7.32e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IRS1—osteoporosis	2.82e-05	7.25e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ADCY5—osteoporosis	2.77e-05	7.14e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SPP1—osteoporosis	2.76e-05	7.1e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—MYC—osteoporosis	2.71e-05	6.97e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—MYC—osteoporosis	2.71e-05	6.97e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TGFB1—osteoporosis	2.7e-05	6.96e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TGFB1—osteoporosis	2.7e-05	6.96e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SPP1—osteoporosis	2.68e-05	6.91e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6R—osteoporosis	2.67e-05	6.88e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6R—osteoporosis	2.67e-05	6.88e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IRS2—osteoporosis	2.66e-05	6.86e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL6—osteoporosis	2.65e-05	6.82e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6R—osteoporosis	2.64e-05	6.81e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MYC—osteoporosis	2.64e-05	6.8e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TGFB1—osteoporosis	2.63e-05	6.78e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ADCY5—osteoporosis	2.61e-05	6.71e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—LEP—osteoporosis	2.61e-05	6.71e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IRS1—osteoporosis	2.6e-05	6.7e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CA2—osteoporosis	2.56e-05	6.6e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—OXCT1—osteoporosis	2.56e-05	6.6e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL6—osteoporosis	2.54e-05	6.55e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SPP1—osteoporosis	2.52e-05	6.49e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MGLL—osteoporosis	2.5e-05	6.43e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IRS2—osteoporosis	2.49e-05	6.42e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—ESR1—osteoporosis	2.49e-05	6.41e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6R—osteoporosis	2.44e-05	6.29e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—LEP—osteoporosis	2.44e-05	6.28e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IRS2—osteoporosis	2.42e-05	6.25e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL6—osteoporosis	2.42e-05	6.23e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MYC—osteoporosis	2.41e-05	6.22e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TGFB1—osteoporosis	2.41e-05	6.2e-05	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL6—osteoporosis	2.39e-05	6.17e-05	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL6—osteoporosis	2.39e-05	6.17e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ADCY5—osteoporosis	2.38e-05	6.14e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—LEP—osteoporosis	2.37e-05	6.11e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—ESR1—osteoporosis	2.33e-05	6e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IRS1—osteoporosis	2.32e-05	5.99e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SPP1—osteoporosis	2.31e-05	5.94e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—POMC—osteoporosis	2.29e-05	5.9e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IRS2—osteoporosis	2.28e-05	5.87e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—ESR1—osteoporosis	2.27e-05	5.84e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TGFB1—osteoporosis	2.26e-05	5.82e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MYC—osteoporosis	2.24e-05	5.78e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MYC—osteoporosis	2.24e-05	5.78e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—POMC—osteoporosis	2.24e-05	5.77e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TGFB1—osteoporosis	2.24e-05	5.76e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TGFB1—osteoporosis	2.24e-05	5.76e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—IL6—osteoporosis	2.23e-05	5.75e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—LEP—osteoporosis	2.23e-05	5.75e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IL6—osteoporosis	2.21e-05	5.7e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—IL6—osteoporosis	2.2e-05	5.67e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL1B—osteoporosis	2.2e-05	5.67e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6R—osteoporosis	2.18e-05	5.62e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IRS1—osteoporosis	2.18e-05	5.61e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IGF1—osteoporosis	2.15e-05	5.55e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—ESR1—osteoporosis	2.13e-05	5.49e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—IDH2—osteoporosis	2.12e-05	5.47e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IRS1—osteoporosis	2.12e-05	5.45e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—POMC—osteoporosis	2.1e-05	5.4e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IRS2—osteoporosis	2.09e-05	5.37e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MYC—osteoporosis	2.08e-05	5.36e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TGFB1—osteoporosis	2.07e-05	5.34e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MYC—osteoporosis	2.05e-05	5.29e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TGFB1—osteoporosis	2.05e-05	5.27e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6R—osteoporosis	2.04e-05	5.27e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—LEP—osteoporosis	2.04e-05	5.26e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—POMC—osteoporosis	2.04e-05	5.25e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—osteoporosis	2.03e-05	5.24e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—osteoporosis	2.03e-05	5.24e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—osteoporosis	2.02e-05	5.21e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IGF1—osteoporosis	2.02e-05	5.19e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL1B—osteoporosis	2.01e-05	5.18e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MYC—osteoporosis	2e-05	5.15e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP27A1—osteoporosis	2e-05	5.14e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TGFB1—osteoporosis	1.99e-05	5.14e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IRS1—osteoporosis	1.99e-05	5.13e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6R—osteoporosis	1.99e-05	5.12e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—osteoporosis	1.98e-05	5.11e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF1—osteoporosis	1.96e-05	5.05e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.96e-05	5.04e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.95e-05	5.03e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—ESR1—osteoporosis	1.95e-05	5.02e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ACP5—osteoporosis	1.94e-05	5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—POMC—osteoporosis	1.92e-05	4.94e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6R—osteoporosis	1.87e-05	4.82e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF1—osteoporosis	1.84e-05	4.75e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.83e-05	4.71e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.82e-05	4.7e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IRS1—osteoporosis	1.82e-05	4.69e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—osteoporosis	1.81e-05	4.67e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TPI1—osteoporosis	1.8e-05	4.65e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—POMC—osteoporosis	1.75e-05	4.52e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6R—osteoporosis	1.71e-05	4.4e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—P4HB—osteoporosis	1.7e-05	4.37e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—osteoporosis	1.69e-05	4.34e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—osteoporosis	1.69e-05	4.34e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF1—osteoporosis	1.69e-05	4.34e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GAPDH—osteoporosis	1.67e-05	4.29e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—osteoporosis	1.65e-05	4.24e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—RAP1A—osteoporosis	1.62e-05	4.18e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MYC—osteoporosis	1.58e-05	4.08e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MYC—osteoporosis	1.58e-05	4.08e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—osteoporosis	1.58e-05	4.07e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—osteoporosis	1.58e-05	4.07e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—osteoporosis	1.56e-05	4.03e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—osteoporosis	1.54e-05	3.97e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—osteoporosis	1.54e-05	3.97e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—osteoporosis	1.5e-05	3.87e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—osteoporosis	1.5e-05	3.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MYC—osteoporosis	1.45e-05	3.73e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—osteoporosis	1.44e-05	3.72e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—osteoporosis	1.41e-05	3.63e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ENO1—osteoporosis	1.31e-05	3.38e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MYC—osteoporosis	1.29e-05	3.33e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PSMA5—osteoporosis	1.29e-05	3.33e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PSMA2—osteoporosis	1.29e-05	3.33e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—osteoporosis	1.29e-05	3.32e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—osteoporosis	1.29e-05	3.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—osteoporosis	1.29e-05	3.32e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MYC—osteoporosis	1.21e-05	3.12e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—osteoporosis	1.21e-05	3.11e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—osteoporosis	1.19e-05	3.06e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—osteoporosis	1.19e-05	3.06e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MYC—osteoporosis	1.18e-05	3.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—osteoporosis	1.18e-05	3.03e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—osteoporosis	1.18e-05	3.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MYC—osteoporosis	1.11e-05	2.85e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—osteoporosis	1.11e-05	2.85e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—osteoporosis	1.09e-05	2.8e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP19A1—osteoporosis	1.05e-05	2.7e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MYC—osteoporosis	1.01e-05	2.61e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—osteoporosis	1.01e-05	2.6e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—osteoporosis	9.73e-06	2.51e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—osteoporosis	9.11e-06	2.35e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—osteoporosis	8.86e-06	2.28e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ADCY5—osteoporosis	8.56e-06	2.21e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GPX1—osteoporosis	8.53e-06	2.2e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—osteoporosis	8.33e-06	2.15e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MTHFR—osteoporosis	7.88e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—osteoporosis	7.62e-06	1.96e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—POMC—osteoporosis	6.3e-06	1.62e-05	CbGpPWpGaD
